Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by hydrocarbsson Sep 13, 2019 2:04pm

155 Views

Post# 30124632

Short Interest from the OTC site

SHORT INTEREST

DATE	SHORT INTEREST	% CHANGE	AVG. DAILY SHARE VOL	DAYS TO COVER	SPLIT	NEW ISSUE
08/15/2019	223,977	-51.59	1,218,373	1	No	No
07/31/2019	462,645	-45.70	376,171	1.23	No	No
07/15/2019	852,041	2.04	162,107	5.26	No	No
06/28/2019	834,966	3.39	257,153	3.25	No	No
06/14/2019	807,626	-0.59	71,722	11.26	No	No
05/31/2019	812,426	39.22	307,394	2.64	No	No
05/15/2019	583,550	-38.26	182,254	3.2	No	No
04/30/2019	945,218	1.53	289,803	3.26	No	No
04/15/2019	687,380	7.11	155,826	4.41	No	No
03/29/2019	687,380	7.11	155,826	4.41	No	No